Ginger: A Nutraceutical Supplement for Protection Against Various Cardiovascular Diseases in Clinical Trials
- PMID: 40255738
- PMCID: PMC12007927
- DOI: 10.7759/cureus.80841
Ginger: A Nutraceutical Supplement for Protection Against Various Cardiovascular Diseases in Clinical Trials
Abstract
Cardiovascular diseases (CVDs) are increasing in prevalence, causing significant health issues and remaining one of the leading causes of death worldwide. Medical herbs continue to be used as an alternative treatment approach for several diseases, including various CVDs. Since ancient times, certain herbs have been safely used to alleviate the risk of developing CVD and control or improve the symptoms of medical conditions, such as in cases of congestive heart failure, angina, atherosclerosis, and systolic hypertension. Ginger is one of the medicinal herbs that neutral agents use to prevent and treat various CVDs. Ginger has antioxidant, anti-inflammatory, and immunomodulatory components and may improve cardiovascular risk factors. The natural components of ginger effectively inhibit inflammation, oxidative stress, and insulin resistance; may reduce fasting blood glucose, triglyceride, and low-density lipoprotein (LDL) levels; and prevent CVDs. Ginger can be an alternative that has lower side effects. Ginger's bioactive components may improve human blood lipid profile and decrease blood sugar levels. Further research is necessary to confirm ginger phytochemicals' efficacy and mechanism for various CVDs. The present review aims to summarize the effects of ginger's bioactive compounds on cardiovascular diseases.
Keywords: atherosclerosis; ginger; gingerols; hyperlipidemia; hypertension; nutraceutical; phytochemical.
Copyright © 2025, Mohammadabadi et al.
Conflict of interest statement
Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
Similar articles
-
A critical review of Ginger's (Zingiber officinale) antioxidant, anti-inflammatory, and immunomodulatory activities.Front Nutr. 2024 Jun 6;11:1364836. doi: 10.3389/fnut.2024.1364836. eCollection 2024. Front Nutr. 2024. PMID: 38903613 Free PMC article. Review.
-
Emerging Trends in the Pharmacological and Therapeutic Potential of Ginger: From Traditional Medicine to Nanotechnological Innovations.Curr Pharm Des. 2025 May 8. doi: 10.2174/0113816128372023250324050304. Online ahead of print. Curr Pharm Des. 2025. PMID: 40353422
-
Ginger and its constituents in asthma: a mini-review.J Asthma. 2024 Nov;61(11):1392-1401. doi: 10.1080/02770903.2024.2361779. Epub 2024 Jun 8. J Asthma. 2024. PMID: 38805387 Review.
-
Health benefits of herbs and spices: the past, the present, the future.Med J Aust. 2006 Aug 21;185(S4):S1-S24. doi: 10.5694/j.1326-5377.2006.tb00548.x. Med J Aust. 2006. PMID: 17022438 Review.
-
Ginger: A complementary approach for management of cardiovascular diseases.Biofactors. 2021 Nov;47(6):933-951. doi: 10.1002/biof.1777. Epub 2021 Aug 13. Biofactors. 2021. PMID: 34388275 Review.
References
-
- Cure and prevention of cardiovascular diseases: herbs for heart. Ray S, Saini MK. Clin Phytosci. 2021;7:64.
-
- Traditional herbs: a remedy for cardiovascular disorders. Rastogi S, Pandey MM, Rawat AK. Phytomedicine. 2016;23:1082–1089. - PubMed
-
- Gender differences in cardiovascular disease. Gao Z, Chen Z, Sun A, Deng X. Med Nov Technol Devices. 2019;4:100025.
Publication types
LinkOut - more resources
Full Text Sources